Overall rank by patents
#865
of 49,997 tracked assignees
USPTO PatentsView assignee record - 523 granted patents across 38 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, ELI ranks #865 of 49,997 tracked US assignees by granted-patent volume, with 523 patents across 38 technology areas.
USPTO PatentsView assignee plate
Corpus R865 · US Corporation #865 · 523 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL
Nearest grant-volume peer: United States of America as represented by the Administrator of NASA (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Assa Abloy Americas… · near
60 score
China Tobacco Hunan… · near
60 score
ELI Lilly AND · this assignee
60 score
Graphcore · near
60 score
Holcim Technology · near
60 score
3D Lighting… · lowest
7 score
What this shows ELI's Innovation Score is 59.7/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
ELI Lilly AND Company is a focused PatentsView assignee: 38 CPC subclasses with 61.2% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (62 grants) versus a trough of 35 in 2017. By volume, ELI sits between Lyft, Inc. and University of Virginia Patent Foundation.
From 2019–2021 to 2022–2024, ELI Lilly AND Company moved from 137 to 170 grants (1.24x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #721. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Lyft, Inc.
526 patents
Xiaomi
526 patents
EchoStar Technologies L.L.C.
525 patents
Transportation IP Holdings, LLC
524 patents
United States of America as represented by the Administrator of NASA
523 patents
ELI Lilly AND Company
523 patents
China Academy OF Telecommunications Technology
520 patents
Fresenius Medical Care Holdings, Inc.
520 patents
University of Virginia Patent Foundation
520 patents
What this shows ELI holds 523 patents at rank #865, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #865 in granted patent volume.
Other assignees with the most granted patents in ELI's primary technology class.
Two PlainPatent-derived peer sets for ELI, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (60 here).
Nearest assignees by average claims per patent (13.3 here).
ELI's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
60 Top 4% higher than 96% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 43 | 8.2% |
| 2016 | 42 | 8.0% |
| 2017 | 35 | 6.7% |
| 2018 | 41 | 7.8% |
| 2019 | 39 | 7.5% |
| 2020 | 45 | 8.6% |
| 2021 | 53 | 10.1% |
| 2022 | 56 | 10.7% |
| 2023 | 52 | 9.9% |
| 2024 | 62 | 11.9% |
| 2025partial year | 55 | 10.5% |
Top 15 of 38 technology areas
Overall rank by patents
#865
of 49,997 tracked assignees
59.7 out of 100
What to do with this data
ELI Lilly AND Company's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.